Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Thailand floods kill 71 and hit nearly 909,000 households

    October 13, 2026

    Meta debuts Muse Wonder models for AI agents and coding

    October 13, 2026

    WHO launches 2030 plan for 24-hour health threat detection

    October 13, 2026
    Facebook X (Twitter) Instagram
    haifajournal.comhaifajournal.com
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    haifajournal.comhaifajournal.com
    Home » Cellebrite to Report Second-Quarter 2026 Financial Results on August 13, 2026
    PR Newswire

    Cellebrite to Report Second-Quarter 2026 Financial Results on August 13, 2026

    July 21, 2026
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email

    TYSONS CORNER, Va. and PETAH TIKVA, Israel, July 21, 2026 /PRNewswire/ — Cellebrite DI Ltd. (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced it will report its second-quarter 2026 financial results before the U.S. markets open on Thursday, August 13, 2026.

    Cellebrite Logo

    Later that same morning, Cellebrite will host a live conference call and webcast to review the Company’s financial results for the second quarter of 2026 and discuss its 2026 outlook. Relevant details include:

    Date:

    Thursday, August 13, 2026

    Time:

    8:30 a.m. ET

    Call-In Number:

    785-838-9251 / 833-309-3473

    Conference ID:

    CLBTQ226

    Event URL:

    https://investors.cellebrite.com/events/event-details/cellebrite-q2-2026-financial-results-conference-call-webcast 

    Live Webcast URL:

    https://edge.media-server.com/mmc/p/nsqdfdmm

    In conjunction with the conference call and webcast, historical financial tables and supplemental data will be available on the quarterly results section of the Company’s investor relations website at https://investors.cellebrite.com/financial-information/quarterly-results.

    About Cellebrite 
    Cellebrite‘s (Nasdaq: CLBT) mission is to protect communities, nations and businesses as a global leader in digital investigative and intelligence solutions. More than 7,000 global law enforcement agencies, defense and intelligence organizations and enterprises trust Cellebrite’s AI-powered software portfolio to make forensically sound digital data more accessible and actionable. Cellebrite technology allows customers to accelerate nearly 3 million legally sanctioned investigations annually, enhance sovereign security, elevate operational efficacy and efficiency and enable advanced mobile research and application security. Available via cloud, on-premises and hybrid deployments, Cellebrite’s technology enables its customers around the globe to advance their missions, elevate public safety and safeguard data privacy. To learn more, visit us at www.cellebrite.com and https://investors.cellebrite.com and find us on social media @Cellebrite.

    Investor Relations
    Andrew Kramer
    Vice President, Investor Relations & Treasury
    investors@cellebrite.com 
    +1 973.206.7760

    Media
    Jackie Labrecque
    Director, PR and Executive Communications
    jackie.labrecque@cellebrite.com
    +1 771.241.7010

    Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/cellebrite-to-report-second-quarter-2026-financial-results-on-august-13-2026-302829979.html

    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email

    Related Posts

    Lutris Pharma Announces Positive Updated Phase 2 Data Demonstrating Durable, Mechanism-Directed Benefit of LUT014 Gel for EGFRI-Induced Acneiform Rash at the EADV Congress

    October 1, 2026

    China (Guangzhou) International Building Decoration Fair Looks Ahead to 2027 with Expanded Global Connections

    September 30, 2026

    Arasan to demonstrate the industry’s first MIPI SWI3S™ IP at the MIPI Member meet in Taipei

    September 30, 2026

    Airway Therapeutics Awarded $1.9 Million NIH Grant to Advance Phase 2b/3 Study of Zelpultide Alfa for Prevention of Bronchopulmonary Dysplasia

    September 29, 2026
    Latest News

    Thailand floods kill 71 and hit nearly 909,000 households

    October 13, 2026

    Meta debuts Muse Wonder models for AI agents and coding

    October 13, 2026

    WHO launches 2030 plan for 24-hour health threat detection

    October 13, 2026

    Pakistan imposes governor’s rule in Khyber Pakhtunkhwa

    October 12, 2026

    Oman electricity output grows as water production declines

    October 12, 2026

    EU announces investment in health of almost €170M plan

    October 10, 2026

    Pakistan bears largest share of rising MENAAP poverty

    October 9, 2026

    African Union launches Africa Credit Rating Agency

    October 9, 2026
    © 2026 Haifa Journal | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.